Platform Partnerships Newomics actively collaborates with leading MS platform vendors, including UniESI offerings for Bruker (SEED), Thermo, and Agilent. This creates ready-made entry points to the vendors' customer bases for instrument upgrades, retrofit opportunities, or bundled solutions.

High Sensitivity Edge The core MEA silicon-microfluidic emitter and MnESI source deliver exceptional sensitivity and throughput for analyzing tiny samples like blood and urine, pointing to sales opportunities in metabolomics, clinical labs, and CROs seeking low-volume, high-performance LC-MS solutions.

Platform Integrations Newomics offers adapters and splitters like FSK-AM to integrate their multi-spray platform with existing high-flow LC systems, expanding retrofit and upgrade prospects for labs with current instrumentation.

CE-MS Leadership Strategic emphasis on CE-MS interfaces and collaboration with Advanced Electrophoresis Solutions signals a growing demand for CE-MS workflows, presenting cross-sell and co-development opportunities with labs performing electrophoretic separations.

Market Momentum Exposure to metabolomics communities through events such as MANA and a proven R&D pedigree underscores credibility and market interest in metabolomics labs and biotech clusters, supporting targeted BD outreach by leveraging partnerships, launches, and pilot programs.